Citalopram Tablets Recalled for Temperature Storage Deviation
Cardinal Healthcare is recalling Citalopram 20mg tablets (batch 3131748) nationwide due to exposure to temperatures outside labeled storage conditions during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall without reported illnesses or injuries. The hazard is precautionary—temperature exposure outside storage conditions—with no evidence of actual harm reported. This matches the rubric criterion for precautionary recalls scored as Moderate.
Plain-English summary
Cardinal Healthcare has recalled Citalopram 20mg tablets, batch 3131748, distributed nationwide. The recall is due to a manufacturing quality deviation: the products were exposed to temperatures outside of the storage conditions stated on the label.
The tablets are manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV. The product is packaged as 100 tablets per container. This is a Class II FDA recall.
Consumers with Citalopram tablets from batch 3131748 should check their batch number and contact their healthcare provider or pharmacist with questions about whether their medication is affected.
The recalled product
- Product
- CITALOPRAM (CITALOPRAM)
- Brand
- CITALOPRAM
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — Antidepressant
- Hazard
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 3131748
UPCs (3)
- 0303786232017
- 0303786231010
- 0303786233014
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27